Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation - PubMed (original) (raw)

. 1998 May;285(2):707-15.

Affiliations

PMID: 9580617

Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation

M B Burton et al. J Pharmacol Exp Ther. 1998 May.

Abstract

The objective of this study was to evaluate the effects of kappa-opioid receptor agonists on pressor and visceromotor responses to colorectal distension in awake, unrestrained rats, a model of visceral pain. Because visceral pain can be enhanced in the presence of inflammation, the study was conducted in rats that had been given either intracolonic saline or 5% acetic acid 6 hr before drug administration. We developed a method of staircase colorectal distension as a means of obtaining stimulus-response functions over a short period of time. Kappa-opioid receptor agonists, given i.v. in a cumulative dose paradigm, dose-dependently attenuated both the pressor and visceromotor responses to colorectal distension. In addition, all drugs tested also increased response threshold. The rank order of potency of the drugs tested was: CI977 > U69,593 > U50,488 > or = morphine > or = EMD61,753 > ICI204,448. Effective doses of these drugs were antagonized by naloxone, but not by either of two kappa-opioid receptor-selective antagonists (nor-binaltorphimine and 2-(3,4-dichlorophenyl)-N-methyl-N-(1-[3-isothiocyanate phenyl]-2-[1-pyrrolidinyl]ethyl)-acetamide). Acute inflammation of the colon did not lead to changes in the potency of the agonists tested. The present results provide further evidence that kappa-opioid receptor agonists significantly attenuate visceral nociception and, in conjunction with other information, suggest that a peripherally restricted kappa-opioid receptor agonist would be therapeutically effective in relieving visceral pain.

PubMed Disclaimer

Cited by

Peripheral kappa-opioid agonists for visceral pain.
Rivière PJ. Rivière PJ. Br J Pharmacol. 2004 Apr;141(8):1331-4. doi: 10.1038/sj.bjp.0705763. Epub 2004 Mar 29. Br J Pharmacol. 2004. PMID: 15051626 Free PMC article. Review.
Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
Ko MC, Butelman ER, Woods JH. Ko MC, et al. J Pharmacol Exp Ther. 1999 Apr;289(1):378-85. J Pharmacol Exp Ther. 1999. PMID: 10087027 Free PMC article.
Treatment of Functional Dyspepsia.
Delgado-Aros S, Cremonini F, Talley NJ. Delgado-Aros S, et al. Curr Treat Options Gastroenterol. 2004 Apr;7(2):121-131. doi: 10.1007/s11938-004-0033-1. Curr Treat Options Gastroenterol. 2004. PMID: 15010026
Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.
Li X, Li B, Zhang J, Chen T, Wu H, Shi X, Ma J, Qin J, Tang X, Wang F. Li X, et al. Medicine (Baltimore). 2021 Jan 29;100(4):e24361. doi: 10.1097/MD.0000000000024361. Medicine (Baltimore). 2021. PMID: 33530231 Free PMC article.
kappa -opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action.
Joshi SK, Su X, Porreca F, Gebhart GF. Joshi SK, et al. J Neurosci. 2000 Aug 1;20(15):5874-9. doi: 10.1523/JNEUROSCI.20-15-05874.2000. J Neurosci. 2000. PMID: 10908631 Free PMC article.

Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation - PubMed (original) (raw)